Radioligand Therapy Market Insights For Healthcare Leaders
The radioligand therapy (RLT) market growth reflects a strategic transformation in radiochemistry and isotope production as the field addresses critical supply chain challenges that have historically constrained patient access to lutetium-177 and other therapeutic radioisotopes. Reactor-produced lutetium-177 via neutron activation of ytterbium-176 and accelerator-produced lutetium-177 via...
0 Comments 0 Shares 164 Views 0 Reviews